Canagliflozin and Renal Outcomes in Diabetic Nephropathy
N Engl J Med
.
2019 Sep 12;381(11):1088-1089.
doi: 10.1056/NEJMc1909687.
Authors
Josivan G Lima
1
,
Marcel C Santos
1
,
Breno C Simas
1
Affiliation
1
Federal University of Rio Grande do Norte, Natal, Brazil josivanlima@gmail.com.
PMID:
31509683
DOI:
10.1056/NEJMc1909687
No abstract available
Publication types
Letter
Comment
MeSH terms
Canagliflozin
Diabetes Mellitus, Type 2*
Diabetic Nephropathies*
Humans
Kidney
Sodium-Glucose Transporter 2 Inhibitors*
Substances
Sodium-Glucose Transporter 2 Inhibitors
Canagliflozin